Search

Author/Creator Astone, Antonio

1. Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab. Issue 4 (3rd April 2018)

Authors:
Pizzuti, Laura; Sergi, Domenico; Sperduti, Isabella; Lauro, Luigi Di; Mazzotta, Marco; Botti, Claudio; Izzo, Fiorentino; Marchetti, Luca; Tomao, Silverio; Marchetti, Paolo; Natoli, Clara; Grassadonia, Antonino; Gamucci, Teresa; Mentuccia, Lucia; Magnolfi, Emanuela; Vaccaro, Angela; Cassano, Aless...
Journal:
Cancer biology & therapy
Issue:
Volume 19:Issue 4(2018)
Page Start:
328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting. Issue 7 (7th August 2019)

Authors:
Pizzuti, Laura; Krasniqi, Eriseld; Barchiesi, Giacomo; Della Giulia, Marina; Izzo, Fiorentino; Sanguineti, Giuseppe; Marchetti, Paolo; Mazzotta, Marco; Giusti, Raffaele; Botticelli, Andrea; Gamucci, Teresa; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Iezzi, Laura; Tomao, Silverio; Tomao...
Journal:
International journal of cancer
Issue:
Volume 146:Issue 7(2020)
Page Start:
1917
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Neoadjuvant chemotherapy in triple‐negative breast cancer: A multicentric retrospective observational study in real‐life setting. Issue 3 (27th September 2017)

Authors:
Gamucci, Teresa; Pizzuti, Laura; Sperduti, Isabella; Mentuccia, Lucia; Vaccaro, Angela; Moscetti, Luca; Marchetti, Paolo; Carbognin, Luisa; Michelotti, Andrea; Iezzi, Laura; Cassano, Alessandra; Grassadonia, Antonino; Astone, Antonio; Botticelli, Andrea; Magnolfi, Emanuela; Di Lauro, Luigi; Sergi...
Journal:
Journal of cellular physiology
Issue:
Volume 233:Issue 3(2018:Mar.)
Page Start:
2313
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗